S
Sinotherapeutics Inc
SSE:688247
Sinotherapeutics Inc
SSE:688247
Price:
8.87
CNY
-5.94%
Market Closed
Market Cap:
¥4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sinotherapeutics Inc
SSE:688247
|
CN |
|
H
|
Hugo Boss AG
OTC:BOSSY
|
DE |
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Tata Steel Ltd
NSE:TATASTEEL
|
IN |
Cash Flow Statement
Cash Flow Statement
Sinotherapeutics Inc
Sinotherapeutics Inc
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Stock-Based Compensation |
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(1)
|
7
|
9
|
8
|
(9)
|
(5)
|
1
|
1
|
(1)
|
4
|
(2)
|
(5)
|
(5)
|
(15)
|
(19)
|
(21)
|
|
| Change in Working Capital |
(62)
|
(63)
|
(84)
|
(56)
|
(111)
|
(104)
|
(70)
|
(109)
|
(124)
|
(127)
|
(136)
|
(143)
|
(136)
|
(148)
|
(148)
|
(144)
|
|
| Cash from Operating Activities |
146
N/A
|
125
-14%
|
116
-7%
|
142
+22%
|
73
-49%
|
82
+13%
|
64
-22%
|
57
-12%
|
13
-77%
|
23
+79%
|
68
+195%
|
63
-7%
|
130
+105%
|
167
+28%
|
115
-31%
|
120
+5%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(16)
|
(43)
|
(92)
|
(95)
|
(176)
|
(150)
|
(108)
|
(109)
|
(39)
|
(42)
|
(39)
|
(58)
|
(95)
|
(104)
|
(102)
|
(86)
|
|
| Other Items |
(48)
|
(187)
|
(104)
|
143
|
(24)
|
(150)
|
(120)
|
(535)
|
(69)
|
(143)
|
(64)
|
206
|
(389)
|
(113)
|
(41)
|
(55)
|
|
| Cash from Investing Activities |
(64)
N/A
|
(230)
-258%
|
(196)
+15%
|
48
N/A
|
(200)
N/A
|
(301)
-50%
|
(228)
+24%
|
(643)
-182%
|
(108)
+83%
|
(185)
-72%
|
(103)
+44%
|
147
N/A
|
(484)
N/A
|
(217)
+55%
|
(143)
+34%
|
(141)
+2%
|
|
| Financing Cash Flow | |||||||||||||||||
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(28)
|
(28)
|
0
|
(47)
|
(18)
|
(28)
|
0
|
(28)
|
(28)
|
|
| Other |
(1)
|
(1)
|
(2)
|
376
|
376
|
376
|
377
|
(1)
|
(0)
|
(32)
|
(35)
|
(36)
|
(36)
|
(4)
|
(1)
|
(0)
|
|
| Cash from Financing Activities |
(1)
N/A
|
(1)
-2%
|
(2)
-153%
|
376
N/A
|
376
0%
|
376
+0%
|
377
+0%
|
(29)
N/A
|
(28)
+3%
|
(61)
-114%
|
(82)
-35%
|
(55)
+33%
|
(64)
-17%
|
(32)
+50%
|
(29)
+9%
|
(28)
+4%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(3)
|
(4)
|
2
|
2
|
3
|
3
|
2
|
1
|
2
|
2
|
1
|
0
|
2
|
1
|
(0)
|
0
|
|
| Net Change in Cash |
78
N/A
|
(109)
N/A
|
(81)
+26%
|
569
N/A
|
251
-56%
|
160
-36%
|
215
+34%
|
(615)
N/A
|
(121)
+80%
|
(220)
-82%
|
(115)
+48%
|
156
N/A
|
(416)
N/A
|
(80)
+81%
|
(58)
+28%
|
(49)
+16%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
130
N/A
|
82
-37%
|
24
-71%
|
48
+98%
|
(103)
N/A
|
(68)
+34%
|
(44)
+35%
|
(52)
-18%
|
(26)
+50%
|
(19)
+28%
|
29
N/A
|
5
-83%
|
35
+620%
|
63
+79%
|
13
-80%
|
34
+173%
|
|
Switch to:
Switch to:
See Also
Discover More
